Display options
Share it on

Neuropsychiatr Dis Treat. 2005 Jun;1(2):151-4. doi: 10.2147/nedt.1.2.151.61046.

Changes in peripheral benzodiazepine receptors in patients with bipolar disorder.

Neuropsychiatric disease and treatment

Donatella Marazziti, Bernardo Dell'Osso, Stefano Baroni, Irene Masala, Elena Di Nasso, Gino Giannaccini, Liliana Dell'Osso

Affiliations

  1. Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie University of Pisa Pisa, Italy. [email protected]

PMID: 18568060 PMCID: PMC2413195 DOI: 10.2147/nedt.1.2.151.61046

Abstract

Peripheral benzodiazepine (BDZ) receptors were investigated by means of the binding of the specific ligand (3)H-PK 11195 to platelet membranes in patients suffering from bipolar disorder and in healthy controls. The results showed that the density (Bmax) of peripheral BDZ receptors was significantly higher in patients than in control subjects, with no change in the dissociation constant. No correlation with demographic or clinical features was observed. These findings would suggest that alterations of peripheral BDZ receptors are present in patients suffering from bipolar disorder, but it is premature to conclude whether they may be related to the pathophysiology of the disorder, or are secondary to changes occurring in other systems, such as those regulating the stress response.

Keywords: 3H-PK 11195; benzodiazepine receptors; bipolar disorder; mitochondria; peripheral benzodiazepine receptors

References

  1. Brain Res. 1988 Aug 16;458(1):31-6 - PubMed
  2. J Biol Chem. 1989 Dec 5;264(34):20415-21 - PubMed
  3. Anal Biochem. 1977 Dec;83(2):346-56 - PubMed
  4. Life Sci. 2000 Sep 22;67(18):2221-31 - PubMed
  5. Biochemistry. 1986 Apr 22;25(8):2120-5 - PubMed
  6. Biochem Biophys Res Commun. 1989 Jun 15;161(2):917-22 - PubMed
  7. Acta Psychiatr Scand. 1991 Dec;84(6):537-44 - PubMed
  8. J Affect Disord. 2002 Jun;70(1):27-33 - PubMed
  9. J Biol Chem. 1990 Mar 5;265(7):3772-9 - PubMed
  10. J Neurosci. 1984 Feb;4(2):593-603 - PubMed
  11. Science. 1987 Oct 23;238(4826):539-42 - PubMed
  12. Endocrinology. 1989 Oct;125(4):2083-91 - PubMed
  13. Am J Psychiatry. 1995 Feb;152(2):280-2 - PubMed
  14. Biol Psychiatry. 1998 Feb 15;43(4):306-9 - PubMed
  15. Lymphokine Cytokine Res. 1991 Apr;10(1-2):7-13 - PubMed
  16. Science. 1985 Sep 20;229(4719):1281-3 - PubMed
  17. Life Sci. 1991;48(12):1185-90 - PubMed
  18. Life Sci. 1991;48(4):341-6 - PubMed
  19. Acta Psychiatr Scand. 1990 Aug;82(2):169-73 - PubMed
  20. Psychoneuroendocrinology. 1993;18(1):3-22 - PubMed
  21. J Psychiatr Res. 2003 May-Jun;37(3):187-92 - PubMed
  22. Pharmacol Biochem Behav. 1986 Jun;24(6):1673-7 - PubMed
  23. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9813-6 - PubMed
  24. Brain Res Bull. 1987 Jan;18(1):143-5 - PubMed
  25. Neuropsychobiology. 1994;29(1):8-11 - PubMed
  26. Vitam Horm. 2004;69:117-50 - PubMed
  27. Br J Psychiatry. 1978 Sep;133:239-48 - PubMed
  28. Eur J Pharmacol. 1987 Jun 19;138(2):289-92 - PubMed
  29. Nature. 1979 Aug 2;280(5721):391-4 - PubMed
  30. J Psychiatry Neurosci. 1994 Mar;19(2):136-9 - PubMed
  31. Psychiatry Res. 1998 Dec 14;81(3):363-9 - PubMed
  32. Eur J Pharmacol. 1986 Feb 18;121(2):275-9 - PubMed
  33. Mol Pharmacol. 1982 Jul;22(1):26-32 - PubMed
  34. Life Sci. 1989;44(16):1077-82 - PubMed
  35. Biol Psychiatry. 1990 Oct 1;28(7):641-3 - PubMed
  36. Science. 1977 Nov 25;198(4319):849-51 - PubMed

Publication Types